Bergqvist M - Search Results

1

Molecular profiling using tissue microarrays as a tool to identify predictive biomarkers in laryngeal cancer treated with radiotherapy.

Holgersson G, Ekman S, Reizenstein J, Bergqvist M, Pontén F, Uhlén M, Magnusson K, Jonnalagadda P, Asplund A, Strömberg S, Linder A, Blomquist E, Liljeholm M, Lödén B, Hellström K, Bergström S. Holgersson G, et al. Among authors: bergqvist m. Cancer Genomics Proteomics. 2010 Jan-Feb;7(1):1-7. Cancer Genomics Proteomics. 2010. PMID: 20181625

2

P53 auto-antibodies in non-small cell lung cancer patients can predict increased life expectancy after radiotherapy.

Bergqvist M, Brattström D, Larsson A, Holmertz J, Hesselius P, Rosenberg L, Wagenius G, Brodin O. Bergqvist M, et al. Anticancer Res. 1998 May-Jun;18(3B):1999-2002. Anticancer Res. 1998. PMID: 9677456

3

Radiation treatment of T1-T4 squamous cell carcinoma of the larynx: a retrospective analysis and long-term follow-up of 135 patients.

Bergqvist M, Brodin O, Pouzon A, Linder A, Hesselius P, Blomquist E. Bergqvist M, et al. Anticancer Res. 2002 Mar-Apr;22(2B):1239-42. Anticancer Res. 2002. PMID: 12168932

4

A retrospective study focusing on clinical predictive factors in 126 patients with oesophageal carcinoma.

Dreilich M, Bergström S, Wagenius G, Brattström D, Bergqvist M. Dreilich M, et al. Among authors: bergqvist m. Anticancer Res. 2004 May-Jun;24(3b):1915-20. Anticancer Res. 2004. PMID: 15274376 Free article.

5

The role of circulating anti-p53 antibodies in patients with advanced non-small cell lung cancer and their correlation to clinical parameters and survival.

Bergqvist M, Brattström D, Larsson A, Hesselius P, Brodin O, Wagenius G. Bergqvist M, et al. BMC Cancer. 2004 Sep 14;4:66. doi: 10.1186/1471-2407-4-66. BMC Cancer. 2004. PMID: 15367333 Free PMC article.

6

The presence of anti-p53 antibodies in sera from patients with oesophageal carcinoma: correlation to treatment, tumour volume and survival.

Bergström S, Dreilich M, Wagenius G, Brattström D, Larsson A, Hesselius P, Bergqvist M. Bergström S, et al. Among authors: bergqvist m. In Vivo. 2004 Sep-Oct;18(5):615-20. In Vivo. 2004. PMID: 15523902 Free article.

7

The role of cystatin C and the angiogenic cytokines VEGF and bFGF in patients with esophageal carcinoma.

Dreilich M, Wagenius G, Bergström S, Brattström D, Larsson A, Hesselius P, Bergqvist M. Dreilich M, et al. Among authors: bergqvist m. Med Oncol. 2005;22(1):29-38. doi: 10.1385/MO:22:1:029. Med Oncol. 2005. PMID: 15750194

8

Newly developed assay measuring cytokeratins 8, 18 and 19 in serum is correlated to survival and tumor volume in patients with esophageal carcinoma.

Brattström D, Wagenius G, Sandström P, Dreilich M, Bergström S, Goike H, Hesselius P, Bergqvist M. Brattström D, et al. Among authors: bergqvist m. Dis Esophagus. 2005;18(5):298-303. doi: 10.1111/j.1442-2050.2005.00504.x. Dis Esophagus. 2005. PMID: 16197528

9

High-risk human papilloma virus (HPV) and survival in patients with esophageal carcinoma: a pilot study.

Dreilich M, Bergqvist M, Moberg M, Brattström D, Gustavsson I, Bergström S, Wanders A, Hesselius P, Wagenius G, Gyllensten U. Dreilich M, et al. Among authors: bergqvist m. BMC Cancer. 2006 Apr 18;6:94. doi: 10.1186/1471-2407-6-94. BMC Cancer. 2006. PMID: 16620378 Free PMC article.

10

Role of circulating cytokeratin fragments and angiogenic factors in NSCLC patients stage IIIa-IIIb receiving curatively intended treatment.

Eriksson P, Brattström D, Hesselius P, Larsson A, Bergström S, Ekman S, Goike H, Wagenius G, Brodin O, Bergqvist M. Eriksson P, et al. Among authors: bergqvist m. Neoplasma. 2006;53(4):285-90. Neoplasma. 2006. PMID: 16830054

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

170 results

Search Page

Filters